JUN and ductal breast carcinoma in situ: Furthermore, transcriptomic studies in normal cells and DCIS have identified that the main signaling pathways modulated by MALINC1 involve processes related to innate and adaptive immune responses, extracellular matrix remodeling, cell adhesion, and the activation of the AP1 signaling pathway [72].